US Stock MarketDetailed Quotes
AMED Amedisys
- 91.240
- -0.170-0.19%
Close Dec 2 16:00 ET
- 91.000
- -0.240-0.26%
Post 17:24 ET
2.99BMarket Cap36.21P/E (TTM)
91.980High90.760Low376.79KVolume91.300Open91.410Pre Close34.47MTurnover1.17%Turnover RatioLossP/E (Static)32.75MShares98.95052wk High2.60P/B2.93BFloat Cap88.80652wk Low--Dividend TTM32.09MShs Float325.120Historical High--Div YieldTTM1.34%Amplitude0.563Historical Low91.477Avg Price1Lot Size
Amedisys Stock Forum
Sign in to post a comment
$Amedisys (AMED.US)$ divergency with good fundamental Also gap so it looks good and risk to rewards is acceptable
1
$Inhibikase Therapeutics (IKT.US)$
learn from
$Amedisys (AMED.US)$
$AMC Entertainment (AMC.US)$
$Fulcrum Therapeutics (FULC.US)$
JonesTrading analyst Soumit Roy initiates coverage on Inhibikase Therapeutics (NASDAQ:IKT) with a Buy rating and announces Price Target of $12.
$PharmaCyte Biotech (PMCB.US)$
learn from
$Amedisys (AMED.US)$
$AMC Entertainment (AMC.US)$
$Fulcrum Therapeutics (FULC.US)$
JonesTrading analyst Soumit Roy initiates coverage on Inhibikase Therapeutics (NASDAQ:IKT) with a Buy rating and announces Price Target of $12.
$PharmaCyte Biotech (PMCB.US)$
2
No comment yet
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
Kofi : Do u see it going above 100 ?